HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA cutbacks

This article was originally published in The Rose Sheet

Executive Summary

Due to a "consistent decrease" in the funding for the agency's Office of Cosmetics & Colors, a "critical mass of expertise is eroding" and will be "greatly reduced as people retire over the next three to four years," OC&C Director John Bailey, PhD, told the Independent Cosmetic Manufacturers & Distributors during a May 21 meeting to discuss congressional budget cuts. Over the past 10 years, "institutional knowledge through hiring and training researchers to succeed current FDA staff has not been maintained," the agency said. FDA additionally noted that the lack of funding has created difficulties in responding to consumer and company needs and requests. ICMAD members were asked to contact congressional members "to request adequate funding be restored" to the Office of Cosmetics & Colors...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005505

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel